If over-the-counter antihistamines aren’t effective for you, your doctor may recommend H2 blockers, steroids, biologics, or ...

All the hairs have disappeared from a three-inch long patch on my left arm. The bare patch is half the width of my arm and extends just onto the back of my left hand.

Discover how exercise-induced urticaria can turn your workout into a challenge, affecting those who love to run.

A runner was forced to quit the sport due to a rare condition that means she’s allergic to water. Erin Cassidy first started ...

The patient has a rash on her cheeks and nose with sparing of the nasolabial folds, in addition to involvement of the dorsal ...

Novartis has secured FDA approval for its BTK inhibitor remibrutinib (Rhapsido) for the treatment of chronic spontaneous urticaria. Remibrutinib is the sixth BTK inhibitor to market in the US, and the ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Please provide your email address to receive an email when new articles are posted on . People with chronic spontaneous urticaria who fail antihistamine treatment previously had to turn to injectables ...

Rhapsido is the first FDA-approved BTKi for CSU, targeting patients unresponsive to H1 antihistamines. REMIX trials showed Rhapsido's superiority over placebo in reducing CSU symptoms by Week 12.

"After one week, I’ve tossed out creams from Beekman, F.A.B., and Biossance because this humble cream outperforms them all," one reviewer wrote.

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

It started out as a simple itch on the lower back of my head and ended with a scratch that kept me up at night. Thinking the annoying red patch that had formed in that area was dry skin, I started ...